4.5 Article

Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis

Journal

ARTHRITIS RESEARCH & THERAPY
Volume 12, Issue 4, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/ar3107

Keywords

-

Categories

Funding

  1. National Institutes of Health [AR055989, T32 AR 055885, K24 AR055989, P60 AR047782, R21 DE018750, R01 AR056215]
  2. Agency for Healthcare Research and Quality
  3. US Food and Drug Administration
  4. WHISCON
  5. RTI Health Solutions
  6. Lewin Group
  7. HealthCore
  8. Pfizer, Inc.
  9. Abbott Immunology
  10. Amgen
  11. BMS
  12. Abbot
  13. Merck Co., Inc.
  14. Novartis
  15. Amgen, Inc.
  16. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR055885, K24AR055989, P60AR047782, R01AR056215] Funding Source: NIH RePORTER
  17. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018750] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Introduction: Although osteoporosis has been reported to be more common in patients with rheumatoid arthritis (RA), little is known whether the risk of osteoporotic fractures in these patients differs by age, sex, and anatomic site. Methods: A retrospective cohort study was conducted using a health care utilization database. Incidence rates (IRs) and rate ratios (RRs) of osteoporotic fractures with 95% confidence intervals (CIs) were calculated. Multivariable Cox proportional hazards models compared the risk of osteoporotic fracture at typical sites between RA and non-RA patients. Results: During a median 1.63-year follow-up, 872 (1.9%) of 47,034 RA patients experienced a fracture. The IR for osteoporotic fracture at typical sites among RA patients was 9.6 per 1,000 person-years, 1.5 times higher than the rate of non-RA patients. The IR was highest for hip fracture (3.4 per 1,000 person-years) in RA. The IRs across all age groups were higher for women than men and increased with older age in both groups. The RRs were elevated in RA patients across all common sites of osteoporotic fracture: hip (1.62, 95% CI 1.43 to 1.84), wrist (1.15, 95% CI 1.00 to 1.32), pelvis (2.02, 95% CI 1.77 to 2.30), and humerus (1.51, 95% CI 1.27 to 1.84). After confounding adjustment, a modest increase in risk for fracture was noted with RA (hazard ratio 1.26, 95% CI 1.15 to 1.38). Conclusions: Our study showed an increased risk of osteoporotic fractures for RA patients across all age groups, sex and various anatomic sites, compared with non-RA patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available